Skip to main content
. Author manuscript; available in PMC: 2012 Dec 14.
Published in final edited form as: Bone. 2008 Nov 27;44(3):404–412. doi: 10.1016/j.bone.2008.10.058

Figure 5.

Figure 5

Effect of central leptin gene therapy and increased body mass (BM) on vertebral (LV3) bone volume/tissue volume (a), trabecular number (b), trabecular thickness (c), and trabecular spacing (d) in ob/ob mice administered either rAAV-GFP (control vector) or rAAV-lep icv (Experiment 2). All data are mean ± SE. *P<0.05. NS, not significant, P>0.05.